Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Notes Payables: 2009-2019

Historic Notes Payables for Fresenius Medical Care AG (FMS) over the last 11 years, with FY2019 value amounting to $1.3 billion.

  • Fresenius Medical Care AG's Notes Payables fell 7941.72% to $358.6 million in Q3 2020 from the same period last year, while for Sep 2020 it was $358.6 million, marking a year-over-year decrease of 7941.72%. This contributed to the annual value of $1.3 billion for FY2019, which is 954.78% down from last year.
  • Fresenius Medical Care AG's Notes Payables amounted to $1.3 billion in FY2019, which was down 954.78% from $1.4 billion recorded in FY2018.
  • Fresenius Medical Care AG's 5-year Notes Payables high stood at $1.4 billion for FY2018, and its period low was $109.3 million during FY2015.
  • Over the past 5 years, Fresenius Medical Care AG's median Notes Payables value was $858.6 million (recorded in 2017), while the average stood at $862.6 million.
  • Per our database at Business Quant, Fresenius Medical Care AG's Notes Payables crashed by 1766.56% in 2015 and then soared by 47962.15% in 2016.
  • Over the past 5 years, Fresenius Medical Care AG's Notes Payables (Annual) stood at $109.3 million in 2015, then soared by 479.62% to $633.2 million in 2016, then skyrocketed by 35.59% to $858.6 million in 2017, then surged by 65.83% to $1.4 billion in 2018, then decreased by 9.55% to $1.3 billion in 2019.
  • Its last three reported values are $1.3 billion in FY2019, $1.4 billion for FY2018, and $858.6 million during FY2017.